4 completed. 4 Phase 4.
By phase and status
Follow HandiHaler: new trials by email Literature Review of HandiHaler trials Research Report on HandiHaler
Trials (filtered) newest first · largest first
All 4 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) budesonide/formoterol, albuterol/salbutamol, FF/UMEC/VI - Pulmonary Disease, Chronic Obstructive | Phase 4 | Completed | 732 | 2018-06-25 | 2020-10-28 |
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) budesonide/formoterol, albuterol/salbutamol, FF/UMEC/VI - Pulmonary Disease, Chronic Obstructive | Phase 4 | Completed | 729 | 2018-06-25 | 2020-10-28 |
A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) FF/UMEC/VI, Tiotropium, Albuterol/salbutamol - Pulmonary Disease, Chronic Obstructive | Phase 4 | Completed | 800 | 2018-03-29 | 2021-07-15 |
Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices ELLIPTA, DISKUS/ACCUHALER, MDI - Pulmonary Disease, Chronic Obstructive | Phase 4 | Completed | 569 | 2014-08-28 | 2017-05-23 |
Conditions studied
Pulmonary Disease, Chronic Obstructive (4)
Sponsors
GlaxoSmithKline (4)
Countries
United States (3) · Czechia (2) · Germany (2) · Netherlands (2) · Poland (1) · Russia (1) · United Kingdom (1)
Results publications
PMID 27883002
NIH funding
2017 (3)